AAAAAA

   
Results: 1-14 |
Results: 14

Authors: SCHUMACHER M HALWACHS G TATZBER F FRUHWALD FM ZWEIKER R WATZINGER N EBER B WILDERSTRUSCHNIG M ESTERBAUER H KLEIN W
Citation: M. Schumacher et al., INCREASED NEOPTERIN IN PATIENTS WITH CHRONIC AND ACUTE CORONARY SYNDROMES, Journal of the American College of Cardiology, 30(3), 1997, pp. 703-707

Authors: HALWACHS G IBERER F PIEBER T MULLER H TSCHELIESSNIGG K TIRAN A SABIN K WILDERSTRUSCHNIG M
Citation: G. Halwachs et al., TROPONIN-T AS A MARKER FOR POSTTRANSPLANTATION ADAPTATIONAL PROBLEMS OF THE DONOR HEART, The Journal of heart and lung transplantation, 15(5), 1996, pp. 451-455

Authors: IBERER F TSCHELIESSNIGG K HALWACHS G AUER T WASLER A PETUTSCHNIGG B SCHREIER G MULLER H ALLMAYR T PRENNER G HIPMAIR G GRASSER B FREIGASSNER M
Citation: F. Iberer et al., CYTOMEGALOVIRUS ANTIGENEMIA AS A MARKER FOR ANTIVIRAL THERAPY AFTER HEART-TRANSPLANTATION, The Journal of heart and lung transplantation, 15(3), 1996, pp. 314-315

Authors: HUBER PR BISCHOF P KRETSCHMER R TRUSCHNIG M HALWACHS G SCHMIDT M
Citation: Pr. Huber et al., CA-15-3 - A MULTICENTER EVALUATION OF AUTOMATED AND MANUAL TESTS, European journal of clinical chemistry and clinical biochemistry, 34(1), 1996, pp. 77-84

Authors: IBERER F TSCHELIESSNIGG K HALWACHS G REHAK P WASLER A PETUTSCHNIGG B SCHREIER G MULLER H ALLMAYER T FREIGASSNER M PRENNER G HIPMAIR G GRASSER B
Citation: F. Iberer et al., DEFINITIONS OF CYTOMEGALOVIRUS DISEASE AFTER HEART-TRANSPLANTATION - ANTIGENEMIA AS A MARKER FOR ANTIVIRAL THERAPY, Transplant international, 9(3), 1996, pp. 236-242

Authors: STAUBER RE VOLLMANN H PESSERL I JAUK B LIPP R HALWACHS G WILDERSTRUSCHNIG M
Citation: Re. Stauber et al., CARBOHYDRATE-DEFICIENT TRANSFERRIN IN HEALTHY WOMEN - RELATION TO ESTROGENS AND IRON STATUS, Alcoholism, clinical and experimental research, 20(6), 1996, pp. 1114-1117

Authors: REISINGER E WENDELIN I GASSER R HALWACHS G WILDERSTRUSCHNIG M KREJS G
Citation: E. Reisinger et al., ANTIBIOTICS AND INCREASED TEMPERATURE AGAINST BORRELIA-BURGDORFERI IN-VITRO, Scandinavian journal of infectious diseases, 28(2), 1996, pp. 155-157

Authors: SCHUMACHER M EBER B TATZBER F KAUFMANN P HALWACHS G FRUHWALD FM ZWEIKER R ESTERBAUER H KLEIN W
Citation: M. Schumacher et al., TRANSIENT REDUCTION OF AUTOANTIBODIES AGAINST OXIDIZED LDL IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Free radical biology & medicine, 18(6), 1995, pp. 1087-1091

Authors: HORINA JH MULLEGGER RR HORN S HOLZER H HALWACHS G KERL H WOLF P
Citation: Jh. Horina et al., PHOTOPHERESIS FOR RENAL-ALLOGRAFT REJECTION, Lancet, 346(8966), 1995, pp. 61-61

Authors: IBERER F TSCHELIESSNIGG KH HALWACHS G AUER T WASLER A PETUTSCHNIGG B MULLER H FREIGASSNER M ALLMAYR T HIPMAIR G PRENNER G GRASSER B
Citation: F. Iberer et al., CMV ANTIGENEMIA (THE LOWER MATRIX PROTEIN PP65), A MARKER FOR THE GUIDANCE OF ANTIVIRAL THERAPY IN CYTOMEGALOVIRUS DISEASE AFTER ORTHOTOPICHEART-TRANSPLANTATION, Wiener Klinische Wochenschrift, 107(23), 1995, pp. 718-722

Authors: IBERER F TSCHELIESSNIGG K HALWACHS G AUER T WASLER A PETUTSCHNIGG B SCHREIER G MULLER H ALLMAYER T PRENNER G HIPPMAIR G GRASSER B FREIGASSNER M
Citation: F. Iberer et al., CYTOMEGALOVIRUS AFTER HEART-TRANSPLANTATION - DEFINITIONS FOR THE GUIDANCE OF ANTIVIRAL THERAPY, Scandinavian journal of infectious diseases, 1995, pp. 100-103

Authors: SCHUMACHER M EBER B HALWACHS G FRUHWALD FM ZWEIKER R POKAN R WILDERSTRUSCHNIG M KLEIN W
Citation: M. Schumacher et al., DEPENDENCE OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-1 AND RECEPTOR-2VALUES ON THE SEVERITY AND DURATION OF ISCHEMIC-HEART-DISEASE, Circulation, 92(11), 1995, pp. 3362-3362

Authors: HALWACHS G TIRAN A REISINGER EC ZACH R SABIN K FOLSCH B LANZER H HOLZER H WILDERSTRUSCHNIG M
Citation: G. Halwachs et al., SERUM LEVELS OF THE SOLUBLE RECEPTOR FOR TUMOR-NECROSIS-FACTOR IN PATIENTS WITH RENAL-DISEASE, The Clinical investigator, 72(6), 1994, pp. 473-476

Authors: HALWACHS G ZACH R POGGLITSCH H HOLZER H TIRAN A IBERER F WASLER A TSCHELIESSNIGG HP LANZER G FOLSCH B WILDERSTRUSCHNIG M
Citation: G. Halwachs et al., A RAPID IMMUNOCYTOCHEMICAL ASSAY FOR CMV DETECTION IN PERIPHERAL-BLOOD OF ORGAN-TRANSPLANTED PATIENTS IN CLINICAL-PRACTICE, Transplantation, 56(2), 1993, pp. 338-342
Risultati: 1-14 |